FindTrial
Sign In

AVB-620

DRUG2 trials

Sponsors

Avelas Biosciences, Inc.

Conditions

Breast CancerBreast Cancer FemaleCarcinoma BreastCarcinoma, Ductal, BreastPrimary Invasive Malignant Neoplasm of Female BreastStage I Breast CancerStage II Breast CancerStage III Breast Cancer

Phase 1

Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery
CompletedNCT02391194
Avelas Biosciences, Inc.Breast Cancer
Start: 2015-04-30End: 2017-01-31Updated: 2017-03-22

Phase 2

Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
CompletedNCT03113825
Avelas Biosciences, Inc.Breast Cancer Female, Carcinoma Breast, Carcinoma, Ductal, Breast +4
Start: 2017-07-05End: 2020-11-18Updated: 2021-06-11